PDCD1 and renal cell carcinoma: Levels of T cells expressing PD-1 are upregulated in patients with high-risk renal cell carcinoma and patients with PD-1-positive T cells are at a significantly higher risk of cancer-specific death compared with patients harboring low PD-1-expressing T cells (Thompson et al., 2007).